Comments on: RB1 gene mutations underlie clinical resistance to CDK 4/6 inhibitor breast cancer therapy

Comments on: RB1 gene mutations underlie clinical resistance to CDK 4/6 inhibitor breast cancer therapy https://bioengineer.org/rb1-gene-mutations-underlie-clinical-resistance-to-cdk-4-6-inhibitor-breast-cancer-therapy/ Bioengineering Tue, 10 Apr 2018 23:00:00 +0000 hourly 1 https://wordpress.org/?v=7.1.3